Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 21
 
Share:
Share:
Image in intervention

Dissection of epigastric artery after percutaneous coronary intervention with Impella CP device

Szymon Glanowski
1
,
Bartłomiej Pietryka
1
,
Michał Okarski
2
,
Łukasz Niewiara
3
,
Jacek Legutko
3
,
Paweł Kleczyński
3

  1. Students’ Scientific Group of Modern Cardiac Therapy at the Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
  2. Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Krakow, Poland
  3. Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Krakow, Poland
Adv Interv Cardiol 2025; 21, 2 (80): 278–279
Online publish date: 2025/05/30
Article file
Get citation
 
 

Patients with multivessel coronary artery disease (MVD) and reduced left ventricle ejection fraction (LVEF) present a challenging population sometimes requiring short-term mechanical circulatory support (MCS), such as the Impella CP device [1]. Optimal planning and prevention of its complications plays a vital role in patients’ prognosis [2].

A 74-year-old woman with MVD and multiple comorbidities – hypertension, obesity with body mass index of 38 kg/m2, anemia, hyperlipidemia, insulin-treated type II diabetes mellitus, class II chronic coronary syndrome according to Canadian Cardiovascular Society, chronic heart failure with a reduced LVEF of 20% and recurrent cardiac decompensations – on dual antiplatelet therapy (clopidogrel) was admitted to undergo an elective percutaneous coronary intervention (PCI), after being deemed eligible by a Heart Team.

The patient underwent computed tomography angiography (angioCT) to evaluate the access site and femoral arteries, which showed bilateral presence of calcified lesions and tortuosity (Figure 1 A). The lesions were more significant on the left side, so the right common femoral artery (RCFA) was chosen as a large-bore access site.

Figure 1

A – Rendered computed tomography angiography, femoral bifurcation and iliac arteries (arrow: tortuosity of right external iliac artery). B – Coronarography of left and right coronary artery, before percutaneous coronary intervention (PCI). C – Coronarography of left and right coronary artery, after PCI. D – Computed tomography angiography, performed after PCI (left arrow: massive contrast extravasation, forming hematoma in the abdominal wall, right arrow: right inferior epigastric artery)

/f/fulltexts/PWKI/56181/PWKI-21-2-56181-g001_min.jpg

Under ultrasound guidance, the RCFA was punctured, and automated mechanical sutures (Abbott, USA) and Prostyle devices were deployed, followed by the insertion of an Impella CP. During the procedure, some resistance was encountered in the iliac artery just beyond the sheath, but the device ultimately crossed and was successfully delivered to the left ventricle. The PCI was performed through right radial access.

Under intravascular ultrasound (IVUS) guidance, angioplasty of the left anterior descending artery (LAD) and the right coronary artery (RCA) (Figure 1 B) with orbital atherectomy was performed. Three drug-eluting stents (Xience 3.0 × 28 mm) were implanted – one in the LAD and two in the RCA (Figure 1 C) – achieving optimal results confirmed by IVUS. Following the procedure, the Impella device was removed, and the vascular access site was closed using 2 Prostyles and AngioSeal 8F (Terumo, Japan).

Postoperatively, the patient rapidly developed symptoms of hypovolemic shock with blood pressure of 70/40 mm Hg. The patient required transfusion of one unit of red blood cells (reserved earlier) and vasopressor infusion. AngioCT confirmed extravasation of contrast from the inferior epigastric artery (Figure 1 D), which formed a massive (28 × 8 × 6 cm) hematoma in the abdominal wall and muscles as a possible complication of external iliac artery tortuosity and the patient’s morbid obesity.

Surgical exploration of the vascular access site revealed minor bleeding from soft tissues. The artery was prepared under direct visualization, with continuous vascular sutures (Prolene 5-0). Prostyle sutures were removed.

The postoperative course was complicated by pneumonia, which was treated empirically with antibiotics. Two weeks after the procedure, after cardiological rehabilitation, the patient was discharged in a stable condition for further out-patient unit care.

Large-bore access PCI carries an increased risk of vascular injuries, hemorrhage, and other complications [3, 4]. Therefore, it is necessary to be prepared for such situations, in terms of meticulous planning (CT), and also by having several units of matched red blood cells reserved prior to the procedure.

Ethical approval

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Turkiewicz K, Rola P, WŁodarczak S, et al. Recovery from severe ischemic cardiomyopathy after high-risk percutaneous coronary intervention facilitated by levosimendan infusion and Impella CP support and prolonged use of a wearable defibrillator vest. Adv Interv Cardiol 2024; 20: 370–71.

2 

Paszek E, Niewiara Ł, Szolc P, et al. Peripheral intravascular lithotripsy paving the way for Impella-assisted multivessel high-risk percutaneous coronary revascularization. Kardiol Pol 2023; 81: 781–3.

3 

Sorrentino S, Di Costanzo A, Salerno N, et al. Strategies to minimize access site-related complications in patients undergoing transfemoral artery procedures with large-bore devices. Curr Vasc Pharmacol 2024; 22: 79–87.

4 

van Wiechen MP, Ligthart JM, Van Mieghem NM. Large-bore vascular closure: new devices and techniques. Interv Cardiol 2019; 14: 17–21.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.